Evotec

Biology, screening and chemistry services

After the merging of EVOTEC BioSystems AG (originally founded in Hamburg in 1993) and Oxford Asymmetry International (OAI), Evotec OAI was founded in December 2000. The Genion Forschungsgesellschafte mbH has been fully acquired by Evotec OAI.

Dr. Werner Lanthaler (CEO)

Schnackenburgallee 114
D-22525 Hamburg
Germany
Phone: +49-40-560-81-0
Fax: +49-40-560-81-222

The company offers assay development services including fluorescence detection platform, proprietary FCS+plus detection, proprietary algorithms, generic assay formats, assays miniaturised to 1µ/well - reagent and compound consumption minimised, proprietary 2080-well plate, proprietary benchtop and automated liquid handling stations.
The company applies its EVOscreen®, a platform for high-throughput screening
Analysis services inlcude developed methods such as achiral HPLC and GC assay method, achiral HPLC and GC impurities method, chiral HPLC and GC method, GC and GC-HS method for residual solvents and the LC-MS method.